|
KMID : 0043320150380050826
|
|
Archives of Pharmacal Research
2015 Volume.38 No. 5 p.826 ~ p.833
|
|
|
Determination of the R-enantiomer of valsartan in pharmaceutical formulation by capillary electrophoresis
|
|
Lee Kyung-Ran
Nguyen NgocVan Thi
Lee Yong-Jae
Choi Seung-Ho
Kang Jong-Seong
Mar Woong-Chon
Kim Kyeong-Ho
|
|
|
Abstract
|
|
|
|
Capillary zone electrophoresis was successfully applied to the enantiomeric purity determination of valsartan using acetyl-β-cyclodextrin (A-β-CD) as a chiral selector. Separations were carried out in a 50 μm, 64/56 cm fused-silica capillary. The optimized conditions included 25 mM phosphate buffer, pH 8.0, containing 10 mM A-β-CD as background electrolyte, an applied voltage of +30 kV and a temperature of 30 °C. Ibuprofen was used as an internal standard. The assay was validated for the R-enantiomer of valsartan in the range of 0.05?3.0 %. The limit of detection was 0.01 %, the limit of quantitation was 0.05 %, relative to a concentration of valsartan of 1 mg/ml. Intra-day precision varied between 2.57 and 5.60 %. Relative standard deviations of inter-day precision ranged between 4.46 and 6.76 % for peak area ratio. The percentage recovery of the R-enantiomer of valsartan ranged between 97.0 and 99.6 % in valsartan product. The assay was applied to the determination of the chiral purity of valsartan tablets and R-enantiomer of valsartan was found as an impurity.
|
|
|
KEYWORD
|
|
|
Valsartan, R-enantiomer, Capillary zone electrophoresis (CZE), Chiral separation, Acetyl-β-cyclodextrin
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|